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Background: Drug-eluting stent (DES) requires long-term dual-antiplatelet therapy (DAT). However, for octogenarians, limited information is 
available regarding the risk of DAT.
Methods: From August 2004 to December 2006, 206 consecutive octogenarians with coronary artery diseases (130 males, mean age 83.3±3.4 
years) underwent elective/emergent stent implantation (104 with bare-metal stent (BMS) and 102 with DES). The patients were followed-up for 
clinical events for an average of 38.0±13.2 months.
Results: Significantly more patients received DAT in DES-group vs. BMS-group (P=0.0027, 1-year: 85.7% vs. 14.8%; 2-year: 74.0% vs. 8.3%; 
3-year: 68.2% vs. 18.9%; 4-year: 85.0% vs. 15.0%, respectively). No differences were observed in MACE, TLR, and TVF between 2 groups. In contrast, 
significantly higher incidences of total as well as major bleeding events were observed in DES-group vs. BMS-group.
Conclusion: : Long-term DAT may increase the likelihood of bleeding complications in octogenarians. Decision-making for DES-implantation 
in octogenarians will require careful assessment of factors that may influence the long-term outcome, including risk of restenosis as well as life 
expectancy.
